Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › Thermo Fisher Licenses Procalcitonin Assay to Siemens Healthineers

Thermo Fisher Licenses Procalcitonin Assay to Siemens Healthineers

Oct 02, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that it has licensed its procalcitonin biomarker assay, BRAHMS PCT, to Siemens Healthineers.

Siemens' Atellica BRAHMS PCT assay received clearance from the US Food and Drug Administration on July 16, which the company announced in August.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Molecular Diagnostics

  1. Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization

  2. UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies

  3. BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark

  4. Progenity to Raise $100M in Separate Public Stock, Private Senior Notes Offerings

  5. Thermo Fisher Scientific Raises Q4 and 2020 Revenue, Earnings Guidance

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.